206 related articles for article (PubMed ID: 3553001)
1. Anti-infectious activity of liposomal muramyl dipeptides in immunodeficient CBA/N mice.
Phillips NC; Chedid L
Infect Immun; 1987 Jun; 55(6):1426-30. PubMed ID: 3553001
[TBL] [Abstract][Full Text] [Related]
2. Activation of murine Kupffer cell tumoricidal activity by liposomes containing lipophilic muramyl dipeptide.
Phillips NC; Rioux J; Tsao MS
Hepatology; 1988; 8(5):1046-50. PubMed ID: 2971013
[TBL] [Abstract][Full Text] [Related]
3. Induction of murine macrophage tumoricidal activity and treatment of experimental pulmonary metastases by liposomes containing lipophilic muramyl dipeptide analogs.
Phillips NC; Chedid L; Bernard JM; Level M; Lefrancier P
J Biol Response Mod; 1987 Dec; 6(6):678-91. PubMed ID: 3450784
[TBL] [Abstract][Full Text] [Related]
4. Augmentation of protective and antibacterial activity induced by muramyl dipeptides in CBA/N defective mice with X-linked immunodeficiency for Salmonella enteritidis infection.
Onozuka K; Saito-Taki T; Nakano M
Infect Immun; 1984 Aug; 45(2):424-7. PubMed ID: 6378798
[TBL] [Abstract][Full Text] [Related]
5. Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs.
Parant MA; Audibert FM; Chedid LA; Level MR; Lefrancier PL; Choay JP; Lederer E
Infect Immun; 1980 Mar; 27(3):826-31. PubMed ID: 7380554
[TBL] [Abstract][Full Text] [Related]
6. In vivo regulation of humoral and cellular immune responses of mice by a synthetic adjuvant, N-acetyl-muramyl-L-alanyl-D-isoglutamine, muramyl dipeptide for MDP.
Leclerc C; Juy D; Bourgeois E; Chedid L
Cell Immunol; 1979 Jun; 45(1):199-206. PubMed ID: 313275
[No Abstract] [Full Text] [Related]
7. Stimulation of mouse resistance to bacterial infection with muramyl dipeptide glycoside.
Kalyuzhin OV; Kalina NG; Bashtanenko AF; Shkalev MV; Kuzovlev FN; Kalyuzhin VV
Bull Exp Biol Med; 2003 May; 135(5):452-5. PubMed ID: 12910284
[TBL] [Abstract][Full Text] [Related]
8. Effect of stearoyl-N-acetylmuramyl-L-alanyl-D-isoglutamine on host resistance to Corynebacterium kutscheri infection in cortisone-treated mice.
Ishihara C; Yamamoto K; Hamada N; Azuma I
Vaccine; 1984 Dec; 2(4):261-4. PubMed ID: 6531965
[TBL] [Abstract][Full Text] [Related]
9. Correlation between in vivo anti-Pseudomonas and anti-Candida activities and clearance of carbon by the reticuloendothelial system for various muramyl dipeptide analogs, using normal and immunosuppressed mice.
Fraser-Smith EB; Waters RV; Matthews TR
Infect Immun; 1982 Jan; 35(1):105-10. PubMed ID: 7054119
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of muramyl dipeptide analogs against infections of Pseudomonas aeruginosa or Candida albicans in mice.
Fraser-Smith EB; Matthews TR
Infect Immun; 1981 Dec; 34(3):676-83. PubMed ID: 7333666
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of experimental liver tumor growth in mice by liposomes containing a lipophilic muramyl dipeptide derivative.
Phillips NC; Tsao MS
Cancer Res; 1989 Feb; 49(4):936-9. PubMed ID: 2912563
[TBL] [Abstract][Full Text] [Related]
12. Uveitis induction in the rabbit by muramyl dipeptides.
Waters RV; Terrell TG; Jones GH
Infect Immun; 1986 Mar; 51(3):816-25. PubMed ID: 3949381
[TBL] [Abstract][Full Text] [Related]
13. N-acetyl muramyl dipeptide stimulation of bone resorption in tissue culture.
Dewhirst FE
Infect Immun; 1982 Jan; 35(1):133-7. PubMed ID: 7054120
[TBL] [Abstract][Full Text] [Related]
14. Biological activity of anomeric pairs of lipophilic glycosides of N-acetylmuramyl-L-alanyl-D-isoglutamine.
Kalyuzhin OV; Zemlyakov AE; Kalina NG; Mulik EL; Kuzovlev FN; Makarova OV
Bull Exp Biol Med; 2008 May; 145(5):623-5. PubMed ID: 19145298
[TBL] [Abstract][Full Text] [Related]
15. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
Heymer B; Finger H; Wirsing CH
Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of serum antibody production in mice by oral administration of lipophilic derivatives of muramyl peptides and bacterial lipopolysaccharides with bovine serum albumin.
Ogawa T; Kotani S; Shimauchi H
Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):117-25. PubMed ID: 3713372
[TBL] [Abstract][Full Text] [Related]
17. Nonspecific enhancement of resistance to local bacterial infection in starved mice.
Galland RB; Trachtenberg LS; Rynerson N; Polk HC
Arch Surg; 1982 Feb; 117(2):161-4. PubMed ID: 7034676
[TBL] [Abstract][Full Text] [Related]
18. Well-defined and potent liposomal hepatitis B vaccines adjuvanted with lipophilic MDP derivatives.
Jain V; Vyas SP; Kohli DV
Nanomedicine; 2009 Sep; 5(3):334-44. PubMed ID: 19523433
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of nonspecific resistance to infection induced by muramyl dipeptide analogs substituted in the gamma-carboxyl group and evaluation of N alpha-muramyl dipeptide-N epsilon-stearoyllysine.
Matsumoto K; Otani T; Une T; Osada Y; Ogawa H; Azuma I
Infect Immun; 1983 Mar; 39(3):1029-40. PubMed ID: 6341226
[TBL] [Abstract][Full Text] [Related]
20. Stereo-isomer specific induction of renal cell apoptosis by synthetic muramyl dipeptide (N-acetylmuramyl-L-alanyl-D-isoglutamine).
Langford MP; Chen D; Welbourne TC; Redens TB; Ganley JP
Mol Cell Biochem; 2002 Jul; 236(1-2):63-73. PubMed ID: 12190122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
